AIkido Pharma (NASDAQ:AIKI) Shares Pass Above Two Hundred Day Moving Average – Should You Sell?

AIkido Pharma Inc. (NASDAQ:AIKIGet Free Report) shares crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $3.32 and traded as high as $4.78. AIkido Pharma shares last traded at $4.53, with a volume of 249,163 shares trading hands.

AIkido Pharma Stock Up 3.7 %

The firm has a market capitalization of $24.85 million, a P/E ratio of -1.17 and a beta of 0.93. The business’s 50 day moving average is $5.59 and its two-hundred day moving average is $3.32.

AIkido Pharma Company Profile

(Get Free Report)

AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.

See Also

Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.